Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy.

Cancer research

Wang Q, Morris RJ, Bode AM, Zhang T.
PMID: 34949672
Cancer Res. 2021 Dec 23; doi: 10.1158/0008-5472.CAN-21-2297. Epub 2021 Dec 23.

Because of profound effects observed in carcinogenesis, prostaglandins (PGs), prostaglandin-endoperoxide synthases, and PG receptors are implicated in cancer development and progression. Understanding the molecular mechanisms of PG actions has potential clinical relevance for cancer prevention and therapy. This review...

Cite
Wang Q, Morris RJ, Bode AM, et al. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy. Cancer Res. 2021;doi: 10.1158/0008-5472.CAN-21-2297.
Wang, Q., Morris, R. J., Bode, A. M., & Zhang, T. (2021). Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy. Cancer research, . https://doi.org/10.1158/0008-5472.CAN-21-2297
Wang, Qiushi, et al. "Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy." Cancer research vol. (2021). doi: https://doi.org/10.1158/0008-5472.CAN-21-2297
Wang Q, Morris RJ, Bode AM, Zhang T. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy. Cancer Res. 2021 Dec 23; doi: 10.1158/0008-5472.CAN-21-2297. Epub 2021 Dec 23. PMID: 34949672.
Copy Download .nbib Format: NLM
Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both .

Frontiers in neurology

Calvello R, Lofrumento DD, Perrone MG, Cianciulli A, Salvatore R, Vitale P, De Nuccio F, Giannotti L, Nicolardi G, Panaro MA, Scilimati A.
PMID: 28649222
Front Neurol. 2017 Jun 09;8:251. doi: 10.3389/fneur.2017.00251. eCollection 2017.

Activated microglia secrete an array of pro-inflammatory factors, such as prostaglandins, whose accumulation contributes to neuronal damages. Prostaglandin endoperoxide synthases or cyclooxygenases (COX-1 and COX-2), which play a critical role in the inflammation, are the pharmacological targets of non-steroidal...

Cite
Calvello R, Lofrumento DD, Perrone MG, et al. Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both . Front Neurol. 2017;8:251doi: 10.3389/fneur.2017.00251.
Calvello, R., Lofrumento, D. D., Perrone, M. G., Cianciulli, A., Salvatore, R., Vitale, P., De Nuccio, F., Giannotti, L., Nicolardi, G., Panaro, M. A., & Scilimati, A. (2017). Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both . Frontiers in neurology, 8251. https://doi.org/10.3389/fneur.2017.00251
Calvello, Rosa, et al. "Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both ." Frontiers in neurology vol. 8 (2017): 251. doi: https://doi.org/10.3389/fneur.2017.00251
Calvello R, Lofrumento DD, Perrone MG, Cianciulli A, Salvatore R, Vitale P, De Nuccio F, Giannotti L, Nicolardi G, Panaro MA, Scilimati A. Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both . Front Neurol. 2017 Jun 09;8:251. doi: 10.3389/fneur.2017.00251. eCollection 2017. PMID: 28649222; PMCID: PMC5465243.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries